Lv51
1110 积分 2024-11-10 加入
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
2小时前
待确认
The current state and future directions of RNAi-based therapeutics
2小时前
待确认
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
3小时前
待确认
POS0188 TARGETING COMPLEMENT FACTOR B (CFB) VIA A NOVEL SIRNA THERAPY (AZD6912) TO TREAT INFLAMMATORY ARTHRITIS
3小时前
待确认
Mechanisms and therapeutic insights into MASH-associated fibrosis
1天前
待确认
A researcher’s guide to preclinical mouse NASH models
1天前
待确认
Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes
3天前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
3天前
已完结
RNAi-based drug design: considerations and future directions
6天前
已完结
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
7天前
已完结
皖公网安备34019202002308
